Literature DB >> 21832161

The impact of pre-existing memory on differentiation of newly recruited naive CD8 T cells.

Matthew D Martin1, Thomas C Wirth, Peter Lauer, John T Harty, Vladimir P Badovinac.   

Abstract

One goal of immunization is to generate memory CD8 T cells of sufficient quality and quantity to confer protection against infection. It has been shown that memory CD8 T cell differentiation in vivo is controlled, at least in part, by the amount and duration of infection, Ag, and inflammatory cytokines present early after the initiation of the response. In this study, we used models of anti-vectorial immunity to investigate the impact of pre-existing immunity on the development and differentiation of vector-induced primary CD8 T cell responses. We showed that existing CD8 T cell memory influences the magnitude of naive CD8 T cell responses. However, the differentiation of newly recruited (either TCR-transgenic or endogenous) primary CD8 T cells into populations with the phenotype (CD62L(hi), CD27(hi), KLRG-1(low)) and function (tissue distribution, Ag-driven proliferation, cytokine production) of long-term memory was facilitated when they were primed in the presence of vector-specific memory CD8 T cells of the same or unrelated specificity. Therefore, these data suggested that the presence of anti-vectorial immunity impacts the rate of differentiation of vector-induced naive CD8 T cells, a notion with important implications for the design of future vaccination strategies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21832161      PMCID: PMC3169750          DOI: 10.4049/jimmunol.1100698

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

Review 1.  Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection.

Authors:  Susan M Kaech; E John Wherry
Journal:  Immunity       Date:  2007-09       Impact factor: 31.745

Review 2.  Shaping and reshaping CD8+ T-cell memory.

Authors:  John T Harty; Vladimir P Badovinac
Journal:  Nat Rev Immunol       Date:  2008-02       Impact factor: 53.106

3.  Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8(+) T cell differentiation.

Authors:  Thomas C Wirth; Hai-Hui Xue; Deepa Rai; Jaime T Sabel; Tom Bair; John T Harty; Vladimir P Badovinac
Journal:  Immunity       Date:  2010-07-08       Impact factor: 31.745

4.  Exploiting cross-priming to generate protective CD8 T-cell immunity rapidly.

Authors:  Nhat-Long L Pham; Lecia L Pewe; Courtney J Fleenor; Ryan A Langlois; Kevin L Legge; Vladimir P Badovinac; John T Harty
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

5.  Tracking the total CD8 T cell response to infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts.

Authors:  Deepa Rai; Nhat-Long L Pham; John T Harty; Vladimir P Badovinac
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

6.  Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria.

Authors:  Nathan W Schmidt; Rebecca L Podyminogin; Noah S Butler; Vladimir P Badovinac; Brad J Tucker; Keith S Bahjat; Peter Lauer; Arturo Reyes-Sandoval; Claire L Hutchings; Anne C Moore; Sarah C Gilbert; Adrian V Hill; Lyric C Bartholomay; John T Harty
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-09       Impact factor: 11.205

Review 7.  Promises and challenges for the development of Listeria monocytogenes-based immunotherapies.

Authors:  Dirk G Brockstedt; Thomas W Dubensky
Journal:  Expert Rev Vaccines       Date:  2008-09       Impact factor: 5.217

Review 8.  Diversity in T cell memory: an embarrassment of riches.

Authors:  Stephen C Jameson; David Masopust
Journal:  Immunity       Date:  2009-12-18       Impact factor: 31.745

9.  Impact of preexisting vector-specific immunity on vaccine potency: characterization of listeria monocytogenes-specific humoral and cellular immunity in humans and modeling studies using recombinant vaccines in mice.

Authors:  Meredith L Leong; Johannes Hampl; Weiqun Liu; Shruti Mathur; Keith S Bahjat; William Luckett; Thomas W Dubensky; Dirk G Brockstedt
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

10.  Memory CD8 T-cell compartment grows in size with immunological experience.

Authors:  Vaiva Vezys; Andrew Yates; Kerry A Casey; Gibson Lanier; Rafi Ahmed; Rustom Antia; David Masopust
Journal:  Nature       Date:  2008-11-12       Impact factor: 49.962

View more
  10 in total

1.  Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy.

Authors:  Christopher A Klebanoff; Christopher D Scott; Anthony J Leonardi; Tori N Yamamoto; Anthony C Cruz; Claudia Ouyang; Madhu Ramaswamy; Rahul Roychoudhuri; Yun Ji; Robert L Eil; Madhusudhanan Sukumar; Joseph G Crompton; Douglas C Palmer; Zachary A Borman; David Clever; Stacy K Thomas; Shashankkumar Patel; Zhiya Yu; Pawel Muranski; Hui Liu; Ena Wang; Francesco M Marincola; Alena Gros; Luca Gattinoni; Steven A Rosenberg; Richard M Siegel; Nicholas P Restifo
Journal:  J Clin Invest       Date:  2015-12-14       Impact factor: 14.808

2.  Irradiated tumor cells of lipopolysaccharide stimulation elicit an enhanced anti-tumor immunity.

Authors:  Yuli Li; Guobo Shen; Wen Nie; Zhimian Li; Yaxiong Sang; Binglan Zhang; Yuquan Wei
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-14       Impact factor: 4.553

3.  Memory CD8⁺ T cells can outsource IFN-γ production but not cytolytic killing for antiviral protection.

Authors:  Sanda Remakus; Daniel Rubio; Avital Lev; Xueying Ma; Min Fang; Ren-Huan Xu; Luis J Sigal
Journal:  Cell Host Microbe       Date:  2013-05-15       Impact factor: 21.023

4.  Polymicrobial sepsis alters antigen-dependent and -independent memory CD8 T cell functions.

Authors:  Sean Duong; Stephanie A Condotta; Deepa Rai; Matthew D Martin; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2014-03-19       Impact factor: 5.422

5.  The Timing of Stimulation and IL-2 Signaling Regulate Secondary CD8 T Cell Responses.

Authors:  Shaniya H Khan; Matthew D Martin; Gabriel R Starbeck-Miller; Hai-Hui Xue; John T Harty; Vladimir P Badovinac
Journal:  PLoS Pathog       Date:  2015-10-02       Impact factor: 6.823

6.  Antigen-dependent and -independent contributions to primary memory CD8 T cell activation and protection following infection.

Authors:  Matthew D Martin; Vladimir P Badovinac
Journal:  Sci Rep       Date:  2015-12-10       Impact factor: 4.379

7.  Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of naïve T-cells but no enduring cell-autonomous defects in T-cell function.

Authors:  Robby Markwart; Stephanie A Condotta; Robert P Requardt; Farina Borken; Katja Schubert; Cynthia Weigel; Michael Bauer; Thomas S Griffith; Martin Förster; Frank M Brunkhorst; Vladimir P Badovinac; Ignacio Rubio
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

8.  Phenotypic and Functional Alterations in Circulating Memory CD8 T Cells with Time after Primary Infection.

Authors:  Matthew D Martin; Marie T Kim; Qiang Shan; Ramakrishna Sompallae; Hai-Hui Xue; John T Harty; Vladimir P Badovinac
Journal:  PLoS Pathog       Date:  2015-10-20       Impact factor: 6.823

9.  Memory CD8+ T cells exhibit tissue imprinting and non-stable exposure-dependent reactivation characteristics following blood-stage Plasmodium berghei ANKA infections.

Authors:  Tovah N Shaw; Michael J Haley; Rebecca S Dookie; Jenna J Godfrey; Antonn J Cheeseman; Patrick Strangward; Leo A H Zeef; Ana Villegas-Mendez; Kevin N Couper
Journal:  Immunology       Date:  2021-08-27       Impact factor: 7.397

Review 10.  Influence of Inflammation in the Process of T Lymphocyte Differentiation: Proliferative, Metabolic, and Oxidative Changes.

Authors:  Marco A Moro-García; Juan C Mayo; Rosa M Sainz; Rebeca Alonso-Arias
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.